REVIEW 1 cited by
Explainable Deep Image Classifiers for Skin Lesion Diagnosis
Not yet reviewed by Pith; the record is open.
This paper has not been read by Pith yet. Machine review is queued; the pith claim, tier, and objections will appear here once it completes.
SPECIMEN: schema-true, not a live event
T0 review · schema-true
One-sentence machine reading of the paper's core claim.
pith:XXXXXXXX · record.json · timestamp
read the original abstract
A key issue in critical contexts such as medical diagnosis is the interpretability of the deep learning models adopted in decision-making systems. Research in eXplainable Artificial Intelligence (XAI) is trying to solve this issue. However, often XAI approaches are only tested on generalist classifier and do not represent realistic problems such as those of medical diagnosis. In this paper, we analyze a case study on skin lesion images where we customize an existing XAI approach for explaining a deep learning model able to recognize different types of skin lesions. The explanation is formed by synthetic exemplar and counter-exemplar images of skin lesion and offers the practitioner a way to highlight the crucial traits responsible for the classification decision. A survey conducted with domain experts, beginners and unskilled people proof that the usage of explanations increases the trust and confidence in the automatic decision system. Also, an analysis of the latent space adopted by the explainer unveils that some of the most frequent skin lesion classes are distinctly separated. This phenomenon could derive from the intrinsic characteristics of each class and, hopefully, can provide support in the resolution of the most frequent misclassifications by human experts.
Forward citations
Cited by 1 Pith paper
-
Safer Skin Lesion Classification with Global Class Activation Probability Map Evaluation and SafeML
A pixel-level argmax over per-class Grad-CAM maps, combined with a selective predictor, is proposed to detect unreliable skin lesion classifications.
Discussion (0). Sign in to comment.